Navigation Links
Dr. Lawrence Spivack, a LASIK Eye Surgeon Expert Serving Denver, Colorado, Joins Elite Circle of Surgeons Listed at Trusted LASIK Surgeons
Date:2/18/2009

ten chosen by other eye surgeons, optometrists, opticians, employees of companies that specialize in refractive eye surgery instrumentation or their family members to perform their LASIK eye surgery or other refractive eye surgery procedure.

A certified ophthalmologist by the American Board of Ophthalmology, this highly qualified eye surgeon is a member of the American Academy of Ophthalmology, the International Society of Refractive Surgery, and the American Society of Cataract and Refractive Surgery.     Locally, Dr. Spivack is a member of the Denver Medical Society and the Colorado Society of Eye Physicians and Surgeons.

Lawrence Spivack, M.D. has been honored by both industry professionals and by the media. VISX awarded him the Star Award multiple times for laser vision correction surgery. KCNC in Denver honored him with the "Best LASIK Doctor" award. Dr. Spivack was voted by 5280 Magazine as "Best LASIK Doctor" four years in a row.

Dr. Spivack's dedication to improving vision for others who do not always have the means to afford exceptional eye care is nowhere more evident than the free LASIK eye surgery program for Iraq and Afghanistan veterans of the armed forces, generously sponsored by the doctors and staff at Spivack Vision Center. Dr. Spivack also co-founded the Denver Rescue Mission Eye Clinic, providing eye care for the homeless. In addition, he is a staff member for the Stout Street Medical Center for the Homeless and a Board Member of the Colorado Cancer League and the Tragedy Assisted Program for Survivors.

"Dr. Spivack is among the most experienced refractive surgeons in Colorado," noted James J. Salz, M.D., Chief Executive Officer of Trusted LASIK Surgeons. "He was one of the first to report a series of cases of 'diffuse lamellar keratitis' at a major eye meeting, before this unusual complication of LASIK eye surgery was completely understood. Dr Spivack
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Opening Dedication of the New John G. Rangos Sr. Research Center at the New Childrens Hospital of Pittsburgh of UPMC Campus in Lawrenceville
2. Baltimore LASIK Surgeon Roy Chuck, MD, PhD of the Wilmer Eye Institute at Johns Hopkins Lists with Trusted LASIK Surgeons
3. Hawaii LASIK Eye Surgery Expert Dr. John D. Olkowski Qualifies and Lists with Trusted LASIK Surgeons
4. Top LASIK and Refractive Experts in Trusted LASIK Surgeons Directory Present Research and Educate Their Peers at Annual AAO Meeting in Atlanta
5. Houston LASIK Eye Surgery Expert and Pioneer Jack Holladay, M.D. Joins Influential Group of Eye Surgeons Listed at Trusted LASIK Surgeons
6. Trusted LASIK Surgeons Welcomes LASIK Expert Michael Raizman of Boston to its Unique LASIK Directory
7. Top Refractive Eye Surgeons Listed in Trusted LASIK Surgeons Directory Make Solid Showing at Annual Alcon Symposium
8. Trusted LASIK Surgeons Welcomes Leading LASIK Eye Surgery Expert, Inventor David Huang, M.D., Los Angeles, to Its Unique Lasik Directory Service
9. Trusted LASIK Surgeons Welcomes Mobile Alabama Expert Refractive Eye Surgeon Richard Duffey, M.D. to Its LASIK Directory For Consumers
10. Trusted LASIK Surgeons Welcomes Dallas LASIK Eye Surgery Specialist Dr. R. Wayne Bowman to its LASIK Directory
11. Chicago LASIK Specialist Parag A. Majmudar, M.D. Joins LASIK and Refractive Surgeons Directory at Trusted LASIK Surgeons
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Dr. Lawrence Spivack, a LASIK Eye Surgeon Expert Serving Denver, Colorado, Joins Elite Circle of Surgeons Listed at Trusted LASIK Surgeons
(Date:2/26/2015)... -- S&P Capital IQ (MHFI) announced today that it ... Therapeutics Holdings Inc . MabVax Therapeutics ... focused on the development of vaccine and antibody-based therapies ... cancer. MabVax has discovered a pipeline of human monoclonal ... by patients who have been immunized against targeted cancers. ...
(Date:2/26/2015)... Mass., Feb. 26, 2015   Synageva BioPharma ... biopharmaceutical company developing therapeutic products for rare disorders, ... provided 2015 goals, other key objectives, and financial ... call today at 4:30 p.m. EST to review ... update.  To participate in today,s call by telephone, ...
(Date:2/26/2015)... The Movement for Indefinite Life Extension ... extension technologies and awareness. The event is taking place ... March 21st 2015, in a live Google Hangout broadcast ... Founder of MILE, says, “Our lives are in our ... for Indefinite Life Extension is raising awareness about bio-sciences ...
(Date:2/26/2015)... Feb. 26, 2015 BioEnterprise today announced that ... attracted more than $2 billion in growth funding during ... national investors, strategic sources, state – including the Ohio ... the $2 billion has been raised in the past ... the heels of the BioEnterprise Midwest Healthcare Growth ...
Breaking Biology Technology:S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 2S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 3S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 4S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 5Synageva BioPharma Reports 2014 Full Year Financial Results 2Synageva BioPharma Reports 2014 Full Year Financial Results 3Synageva BioPharma Reports 2014 Full Year Financial Results 4Synageva BioPharma Reports 2014 Full Year Financial Results 5Synageva BioPharma Reports 2014 Full Year Financial Results 6Synageva BioPharma Reports 2014 Full Year Financial Results 7Synageva BioPharma Reports 2014 Full Year Financial Results 8Synageva BioPharma Reports 2014 Full Year Financial Results 9Indefinite Life Extension Activists Organize Online Demonstration 2Indefinite Life Extension Activists Organize Online Demonstration 3More Than $2 Billion Invested in Northeast Ohio Bioscience Start-Up Companies Since 2002 2More Than $2 Billion Invested in Northeast Ohio Bioscience Start-Up Companies Since 2002 3More Than $2 Billion Invested in Northeast Ohio Bioscience Start-Up Companies Since 2002 4
... (NASDAQ: GPRO ) announced today that the Company ... April 28, 2011 at approximately 4:00 pm Eastern Time (ET). ... management at 4:30 pm ET.   The conference ... the investors section of the Company,s web site at ...
... Proteon Therapeutics, Inc. has initiated enrollment in a ... in chronic kidney disease (CKD) patients undergoing surgery for ... study follows successful completion of a 66-patient, double-blind, placebo-controlled ... completed enrollment in July 2010. "Our lead ...
... Texas, April 14, 2011 The Wound Institute today ... dynamic reciprocity at the combined meeting of the Symposium ... Society (WHS) being held in Dallas at the Gaylord ... Presenting faculty are Dr. Ira M. Herman, tenured Professor ...
Cached Biology Technology:Gen-Probe Announces Webcast of First Quarter 2011 Earnings Conference Call 2Proteon Therapeutics Initiates Patient Enrollment in Phase 2 Clinical Study of PRT-201 in Hemodialysis Patients 2The Wound Institute® to Feature Educational Forum on Dynamic Reciprocity During the Symposium on Advanced Wound Care and the Wound Healing Society Annual Meeting 2The Wound Institute® to Feature Educational Forum on Dynamic Reciprocity During the Symposium on Advanced Wound Care and the Wound Healing Society Annual Meeting 3The Wound Institute® to Feature Educational Forum on Dynamic Reciprocity During the Symposium on Advanced Wound Care and the Wound Healing Society Annual Meeting 4
(Date:2/11/2015)... , February 11, 2015 ... research report "Access Control Market by Product (Cards and ... Residential, Military and Defense, Government, Industrial, Healthcare, Education) and ... published by MarketsandMarkets, the Access Control Market ... 2020, growing at a CAGR of 10.6% ...
(Date:2/9/2015)... , Feb. 9, 2015  Lintec of America ... methods for carbon nanotube (CNT) macrostructures, including sheets, yarns ... Dallas (UTD). Leveraging the vast industrial resources ... Tokyo, Japan , Lintec of America is forming ... Richardson, TX , focusing on scaling up the ...
(Date:2/5/2015)... , Feb. 5, 2015  Marken is starting ... company and has launched a new marketing campaign to ... Organization (CLO).  The new campaign focuses on First ... protocol and shipments. The first headline in ... aligns Marken,s priorities with its client,s priorities. Marken recognizes ...
Breaking Biology News(10 mins):Access Control Market Worth $10.4 Billion by 2020 2Access Control Market Worth $10.4 Billion by 2020 3Access Control Market Worth $10.4 Billion by 2020 4Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 2Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 3Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 4Marken Launches New Patient-Centric Campaign 2
... A team of Dutch researchers under the leadership of ... They weakened fear memories in human volunteers by administering ... return over the course of time. Top journal ... 2009. Until recently, it was assumed that ...
... CO More than 300 geoscientists will gather 12-13 ... Section of the Geological Society of America. The meeting ... in St. Petersburg, Florida. , Geoscientists from the University ... the meeting along with the USF Geology Alumni Society. ...
... much salt, and a University of Iowa researcher has discovered ... in a better mood. UI psychologist Kim Johnson and ... in sodium chloride, common table salt, they shy away from ... pressing a bar that stimulates a pleasant sensation in their ...
Cached Biology News:An end to fear 2Study suggests salt might be 'nature's antidepressant' 2Study suggests salt might be 'nature's antidepressant' 3
Recognizes Human Connexin 45. Due to sequence homologies, this antibody is also expected to react with canine (100% homology) and mouse (92% homology) Connexin 45. Also confirmed to work on rat C6 c...
...
... Corning CellBIND surface is produced by a ... hydrophilic surface giving more consistent, even cell ... enhances cell attachment and growth uunder difficult ... • CellBIND may provide a more ecominic ...
Mouse polyclonal antibody raised against a partial recombinant RDH5. NCBI Entrez Gene ID = 5959...
Biology Products: